2025 |
MEI Pharma Inc
|
Chairman of the board |
- |
- |
2024 |
MEI Pharma Inc
|
Chairman of the Board |
117.2 K |
18.1 % |
2024 |
Cellectar Biosciences Inc
|
Independent Director |
- |
- |
2023 |
MEI Pharma Inc
|
Independent Director |
99.2 K |
-34.8 % |
2023 |
Calliditas Therapeutics AB - ADR
|
Independent Director |
- |
- |
2022 |
MEI Pharma Inc
|
Independent Director |
152.1 K |
-7.3 % |
2022 |
Cue Biopharma Inc
|
Independent Director |
143.8 K |
-2.7 % |
2022 |
Cellectar Biosciences Inc
|
Independent Director |
83.0 K |
-34.3 % |
2021 |
ImmunityBio Inc
|
- |
1.2 M |
109.3 % |
2021 |
MEI Pharma Inc
|
Independent Director |
164 K |
34.1 % |
2021 |
Cue Biopharma Inc
|
Independent Director |
147.8 K |
-10.1 % |
2021 |
Cellectar Biosciences Inc
|
Independent Director |
126.3 K |
15.7 % |
2021 |
ImmunityBio Inc
|
Director |
- |
- |
2020 |
ImmunityBio Inc
|
Director |
564.1 K |
- |
2020 |
Cue Biopharma Inc
|
Independent Director |
164.4 K |
85.3 % |
2020 |
MEI Pharma Inc
|
Independent Director |
122.3 K |
-23.1 % |
2020 |
Cellectar Biosciences Inc
|
Independent Director |
109.2 K |
29.8 % |
2019 |
MEI Pharma Inc
|
Independent Director |
158.9 K |
133.4 % |
2019 |
Cue Biopharma Inc
|
Independent Director |
88.8 K |
-82.9 % |
2019 |
Cellectar Biosciences Inc
|
Independent Director |
84.1 K |
16.5 % |
2018 |
Cue Biopharma Inc
|
Independent Director |
518.8 K |
- |
2018 |
Cellectar Biosciences Inc
|
Independent Director |
72.2 K |
33.8 % |
2018 |
MEI Pharma Inc
|
Independent Director |
68.1 K |
- |
2017 |
Cellectar Biosciences Inc
|
Independent Director |
53.9 K |
- |
2016 |
Cellectar Biosciences Inc
|
Director |
- |
- |